Article History
Accepted: 18 May 2023
First Online: 10 July 2023
Compliance with Ethical Standards
:
: Vadim S. Koshkin reports serving in a consulting or advisory role for AstraZeneca, Clovis, Janssen, Pfizer, EMD Serono, Seagen, Astellas, Dendreon, Guidepoint, GLG and receiving institutional research funding from Endocyte/Novartis, Nektar, Clovis, Janssen and Taiho, all unrelated to the current manuscript. Amisha Singh and Appledene S. Osbourne declare no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.